Usted buscó: inhibiitorit (Estonio - Inglés)

muud proteaasi inhibiitorit,
another protease inhibitor

ekstraktis leidub α-glükosidaasi inhibiitorit.
the extract contains an a-glucosidase inhibitor.

cinryze sisaldab toimeainena inimese c1 inhibiitorit.
it contains the active substance c1 inhibitor (human).

kui te võtate muud proteaasi inhibiitorit või elvitegraviiri.
if you are taking another protease inhibitor or elvitegravir.

protopic sisaldab toimeainena takroliimust, kaltsineuriini inhibiitorit.
protopic contains the active substance tacrolimus, a calcineurin inhibitor.

velcade sisaldab toimeainena bortesomiibi, nn proteasoomi inhibiitorit.
velcade contains the active substance bortezomib, a so-called ‘proteasome inhibitor’.

bortezomib sun sisaldab toimeainena bortesomiibi, nn proteasoomi inhibiitorit.
bortezomib sun contains the active substance bortezomib, a so-called ‘proteasome inhibitor’.

bortezomib accord sisaldab toimeainena bortesomiibi, nn proteasoomi inhibiitorit.
bortezomib accord contains the active substance bortezomib, a so-called ‘proteasome inhibitor’.

varasemat ravi mittesaanud patsientidele manustati ka nukleosiidset pöördtranskriptaasi inhibiitorit.
naïve patients also received nucleoside reverse transcriptase inhibitors.

kui te võtate prootonpumba inhibiitorit, võtke seda harvoniga samal ajal.
if you are taking a proton pump inhibitor, take it at the same time as harvoni.

kui kasutate prootonpumba inhibiitorit, peate epclusat võtma koos toiduga;
epclusa should be taken with food when using a proton pump inhibitor.

reproduction is authorised provided the source is acknowledged. proteaasi inhibiitorit kasutanud.
how has viracept been studied?

patsiendid ei tohi kasutada samaaegselt mõnda teist prootonpumba inhibiitorit või h2-antagonisti.
patients should not take another ppi or h2 antagonist concomitantly.

aripiprasooli annust tuleb vähendada kui samaaegselt aripiprasooliga manustatakse ka tugevat cyp3a4 või cyp2d6 inhibiitorit.
when concomitant administration of potent cyp3a4 or cyp2d6 inhibitors with aripiprazole occurs, the aripiprazole dose should be reduced.

emtritsitabiin, retroviirusevastane ravim, mida teatakse kui nukleosiid-pöördtranskriptaasi inhibiitorit (nrti);
emtricitabine, an antiretroviral medicine known as a nucleoside reverse transcriptase inhibitor (nrti)

kokku 356 (7%) uuringu harusse c randomiseeritud patsientidest said gp iib/iiia inhibiitorit.
a total of 356 (7.7%) of patients randomised to arm c also received a gp iib/iiia inhibitor.

kõigis kolmes uuringus kasutasid patsiendid ka kahte pöördtranskriptaasi inhibiitorit (teatud liiki viiruseravim).
in all three studies, the patients also took two reverse transcriptase inhibitors (another type of antiviral medicine).

võrdlusravi sisaldas ritonaviiri abil võimendatud proteaasi inhibiitorit (samuti individuaalselt määratud) ja ofr-i.
the comparator regimen included a ritonavir-boosted pi (also individually defined) plus an obr.

emtritsitabiin, teatud tüüpi retroviirusvastane ravim, mida teatakse kui nukleosiid-pöördtranskriptaasi inhibiitorit (nrti);
emtricitabine, an antiretroviral medicine of a type known as a nucleoside reverse transcriptase inhibitor (nrti)

patsiendid, kellel osutus ebaefektiivseks eelnev ravi, mis sisaldas integraasi inhibiitorit (ja resistentsus integraasi inhibiitorite suhtes)
patients with prior treatment failure that included an integrase inhibitor (and integrase class resistance)